Loading stock data…
WW
$11.90+0.99 (+9.07%)
WW International, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
WW International, Inc. in the Healthcare sector is trading at $11.90. The stock is currently near its 52-week low of $8.91, remaining 53.7% below its 200-day moving average. Technical signals show neutral RSI of 57 and bullish MACD crossover, explaining why WW maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 57) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$11.90
Potential Upside
6220.9%
Whystock Fair Value$752.19
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus3 analysts
Mean target$37.00+210.9%
Range$21.00 – $50.00
Fundamentals
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$99.96M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
1.32
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
326.95%
Volume
Today's trading volume
274,268
Recent News
3 Consumer Stocks That Concern Us
Consumer discretionary businesses are levered to the highs and lows of economic cycles. Thankfully for the industry, demand trends seem to be healthy as discretionary stocks have gained 7.5% over the past six months. This performance has nearly mirrored the S&P 500.
Oral Ozempic US Launch And Partnerships Test Novo Nordisk Valuation
Novo Nordisk (CPSE:NOVO B) is rolling out its oral Ozempic (semaglutide) tablet across the US as the only FDA approved oral GLP-1 for adults with type 2 diabetes. The company plans broad distribution through more than 70,000 US pharmacies. New access partnerships with WW International and GoodRx aim to support patients through digital health tools, discounts and self pay options. The launch includes a mix of insurance coverage pathways and cash pay programs targeting both insured and self...
Novo Nordisk Launches Ozempic Pill in U.S.
Oral version targets broader access as GLP-1 demand grows
Why WeightWatchers (WW) Shares Are Trading Lower Today
Shares of personal wellness company WeightWatchers (NASDAQ:WW) fell 5.3% in the afternoon session after the company announced its intention to prepay up to $40 million in debt and reaffirmed its financial guidance for 2026.
Midday Fly By: Verizon reports ‘beat and raise,’ Shell to acquire ARC
The major averages were broadly lower amid stalled peace negotiations between the U.S. and Iran as well as new escalation in the Strait of Hormuz. Investors are also balancing continued strength in corporate earnings and AI-driven optimism with rising geopolitical tension and macro uncertainty. Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart I